LKMNH:IST
Lokman Hekim Engu Sa Tu Eg Hi v In TA AS
TRY 11.44
arrow_downward
-1.80%(-0.21) 1D
Oct 2, 6:10:00 PM GMT+3 · TRY
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LKMNH...
Open
TRY 11.61
High
TRY 11.65
Low
TRY 11.37
Mkt. cap
2.47B
Avg. vol.
2.26M
Volume
1.72M
Dividend
4.05%
Quarterly dividend
TRY 0.12
Ex-dividend date
Sep 28, 2026
P/E ratio
20.95
52-wk high
TRY 19.44
52-wk low
TRY 11.20
EPS
TRY 0.55
Shares outstanding
216.00M
No. of employees
2K
Open
TRY 11.61
High
TRY 11.65
Low
TRY 11.37
Mkt. cap
2.47B
Avg. vol.
2.26M
Volume
1.72M
Dividend
4.05%
Quarterly dividend
TRY 0.12
Ex-dividend date
Sep 28, 2026
P/E ratio
20.95
52-wk high
TRY 19.44
52-wk low
TRY 11.20
EPS
TRY 0.55
Shares outstanding
216.00M
No. of employees
2K
News stories
From web sources and news partners
TipRanks
·
2 hours ago
Lokman Hekim Details Board Structure and Diversified Healthcare Subsidiaries
TipRanks
·
3 hours ago
Lokman Hekim lifts treasury stake to 6.01% under LKMNH buy-back
TipRanks
·
1 day ago
Lokman Hekim Boosts Treasury Stake Through Share Buy-Back
About Lokman Hekim Engu Sa Tu Eg Hi v In TA AS
Previous reportsAll values in TRY
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in TRY | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 1.02B | 1.28B | 1.27B | 1.29B |
Cost of goods sold | 835.40M | 1.03B | 1.00B | 1.09B |
Cost of revenue | 835.40M | 1.03B | 1.00B | 1.09B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 67.57M | 82.92M | 92.22M | 96.87M |
Operating expense | 60.55M | 111.14M | 25.56M | 69.83M |
Total operating expenses | 895.96M | 1.14B | 1.03B | 1.16B |
Operating income | 125.42M | 139.34M | 244.82M | 124.44M |
Other non operating income | 6.96M | 11.36M | 98.45M | 46.76M |
EBT including unusual items | 59.40M | 130.67M | 73.35M | 66.68M |
EBT excluding unusual items | 59.37M | 126.52M | 73.35M | 66.64M |
Income tax expense | 3.11M | 109.12M | 52.88M | 13.62M |
Effective tax rate | 5.23% | 83.51% | 72.10% | 20.43% |
Other operating expenses | -7.02M | 28.22M | -66.65M | -27.04M |
Net income | 29.75M | 30.68M | 21.12M | 36.40M |
Net profit margin | 2.91% | 2.40% | 1.66% | 2.83% |
Earnings per share | - | - | - | - |
Interest and investment income | 22.09M | 161.83M | 6.64M | 75.11M |
Interest expense | -31.57M | - | -276.57M | -49.21M |
Net interest expenses | -9.49M | 161.83M | -269.92M | 25.89M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 205.79M | 227.27M | 318.03M | 220.77M |
Gain or loss from assets sale | -54.21K | -4.14M | - | - |